Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory Drugs [NSAIDs], Corticosteroids, Colchicine, Urate-Lowering Agents), By Disease Condition (Acute Gout, Chronic Gout), And Segment Forecasts, 2018 - 2025

Table of Content

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Gout Therapeutics Market Variables, Trends & Scope
3.1 Market Segmentation and Scope
3.1.1 Market driver analysis
3.1.1.1 Introduction of urate-lowering agents
3.1.1.2 Rising prevalence of gout
3.1.2 Market restraint analysis
3.1.2.1 Competition from generic drugs
3.1.2.2 High cost of recently launched drugs
3.2 Penetration & Growth Prospects Mapping
3.3 Gout Therapeutics Market - PESTLE Analysis
3.4 Industry Analysis - Porter’s
3.5 Gout Therapeutics Competitive Scenario
3.5.1 Competitive landscape: Market position analysis (based on product portfolio, regional presence, and strategic initiatives)
Chapter 4 Gout Therapeutics: Drug Class Estimates & Trend Analysis
4.1 Global Gout Therapeutics Market: Drug Class Movement Analysis
4.2 NSAIDs
4.2.1 NSAIDs market estimates and forecasts, 2014 - 2025 (USD Million)
4.3 Corticosteroids
4.3.1 Corticosteroids market estimates and forecasts, 2014 - 2025 (USD Million)
4.4 Colchicine
4.4.1 Colchicine market estimates and forecasts, 2014 - 2025 (USD Million)
4.5 Urate-Lowering Agents
4.5.1 Urate-lowering agents market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Gout Therapeutics: Disease Condition Estimates & Trend Analysis
5.1 Global Gout Therapeutics Market: Disease Condition Movement Analysis
5.2 Acute Gout
5.2.1 Acute market estimates and forecasts, 2014 - 2025 (USD Million)
5.3 Chronic Gout
5.3.1 Chronic gout market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Gout Therapeutics: Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2015 & 2025
6.2 North America
6.2.1 North America gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.2.2 North America gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.2.3 U.S.
6.2.3.1 U.S. gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.2.3.2 U.S. gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.2.4 Canada
6.2.4.1 Canada gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.2.4.2 Canadagout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.3 Europe
6.3.1 Europe gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.3.2 Europe gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.3.3 Germany
6.3.3.1 Germany gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.3.3.2 Germanygout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.3.4 UK
6.3.4.1 UK gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.3.4.2 UK gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.4.2 Asia Pacific gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.4.3 Japan
6.4.3.1日本痛风治疗市场,通过药物class, 2014 - 2025 (USD Million)
6.4.3.2 Japan gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.4.5 China
6.4.5.1 China gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.4.5.2 China gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.5 Latin America
6.5.1 Latin America gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.5.2 Latin America gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.5.3 Brazil
6.5.3.1 Brazil gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.5.3.2 Brazilgout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.5.4 Mexico
6.5.4.1 Mexicogout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.5.4.2 Mexicogout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.6 MEA
6.6.1 MEA gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.6.2 MEA gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
6.6.3 South Africa
6.6.3.1 South Africa gout therapeutics market, by drug class, 2014 - 2025 (USD Million)
6.6.3.2 South Africagout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Takeda Pharmaceutical Company Ltd.
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Novartis
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Savient Pharmaceuticals
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Regeneron Pharmaceuticals
7.4.1公司概述
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 AstraZeneca plc
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Horizon Pharma plc
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic Initiatives
7.7 Boehringer Ingelheim
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 Merck & Co. Inc
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 Teijin Pharma Ltd
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 GlaxoSmithKline plc
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives

List of Tables

TABLE 1 Gout therapeutics market - global market current and forecast by regions (2015 - 2024) in (USD Million)
TABLE 2 North America gout therapeutics market estimates and forecasts, by country, 2014 - 2025 (USD Million)
TABLE 3 North America gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 4 North America gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 5 U.S. gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 6 U.S. gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
表7加拿大痛风rapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 8 Canada gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 9 Europe gout therapeutics market estimates and forecasts, by country, 2014 - 2025 (USD Million)
TABLE 10 Europe gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 11 Europe gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 12 UK gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 13 UK gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 14 Germany gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 15 Germany gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 16 Asia Pacific gout therapeutics market estimates and forecasts, by region, 2014 - 2025 (USD Million)
TABLE 17 Asia Pacific gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 18 Asia Pacific gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 19 Japan gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 20 Japan gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 21 China gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 22 China gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 23 Latin America gout therapeutics market estimates and forecasts, by country, 2014 - 2025 (USD Million)
TABLE 24 Latin America gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 25 Latin America gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 26 Brazil gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 27 Brazil gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 28 Mexico gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 29 Mexico gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 30 MEA gout therapeutics market estimates and forecasts, by country, 2014 - 2025 (USD Million)
TABLE 31 MEA gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 32 MEA gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)
TABLE 33 South Africa gout therapeutics market estimates and forecasts, by drug class, 2014 - 2025 (USD Million)
TABLE 34 South Africa gout therapeutics market estimates and forecasts, by disease condition, 2014 - 2025 (USD Million)

List of Figures

无花果. 1 Market research process
无花果. 2 Information procurement
无花果. 3 Primary research pattern
无花果. 4 Market research approaches
无花果. 5 Value chain based sizing & Forecasting
无花果. 6 QFD modeling for market share assessment
无花果. 7 Market summary
无花果. 8 Market trends & outlook
无花果. 9 Market segmentation & scope
无花果. 10 Market driver relevance analysis (Current & future impact)
无花果. 11 Market restraint relevance analysis (Current & future impact)
无花果. 12 Penetration & growth prospect mapping
无花果. 13 Gout therapeutics market - PESTLE analysis
无花果. 14 Porter’s Five Forces Analysis
无花果. 15 Gout therapeutics market outlook key takeaways
无花果. 16 Gout therapeutics market: drug class movement analysis
图17全球痛风治疗市场,通过药物class, 2014 - 2025 (USD Million)
无花果. 18 Global gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 19 Global NSAIDs market, 2014 - 2025 (USD Million)
无花果. 20 Global corticosteroids market, 2014 - 2025 (USD Million)
无花果. 21 Global colchicine market, 2014 - 2025 (USD Million)
无花果. 22 Global urate-lowering agents market, 2014 - 2025 (USD Million)
无花果. 23 Global gout therapeutics market: disease condition movement analysis
无花果. 24 Global gout therapeutics market, by disease condition, 2014 - 2025 (USD Million)
无花果. 25 Global acute gout market, 2014 - 2025 (USD Million)
无花果. 26 Global chronic gout market, 2014 - 2025 (USD Million)
无花果. 27 Regional market: Key takeaways
无花果. 28 Gout therapeutics market regional outlook, 2015 & 2024
无花果. 29 North America gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 30 U.S. gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 31 Canada gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 32 Europe gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 33 Germany gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 34 UK gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 35 Asia Pacific gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 36 Japan gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 37 China gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 38 Latin America gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 39 Brazil gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 40 Mexico gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 41 Middle East Africa gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 42 South Africa gout therapeutics market, 2014 - 2025 (USD Million)
无花果. 43 Strategy frameworks